NEXTEDIA (ALNXT.PA) Fundamental Analysis & Valuation

EPA:ALNXT • FR0004171346

Current stock price

0.37 EUR
-0.01 (-2.63%)
Last:

This ALNXT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALNXT.PA Profitability Analysis

1.1 Basic Checks

  • ALNXT had positive earnings in the past year.
  • In the past year ALNXT had a positive cash flow from operations.
  • Each year in the past 5 years ALNXT has been profitable.
  • ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.83%, ALNXT is in line with its industry, outperforming 42.25% of the companies in the same industry.
  • ALNXT's Return On Equity of 4.93% is on the low side compared to the rest of the industry. ALNXT is outperformed by 60.56% of its industry peers.
  • ALNXT's Return On Invested Capital of 6.30% is in line compared to the rest of the industry. ALNXT outperforms 43.66% of its industry peers.
  • ALNXT had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 10.82%.
  • The 3 year average ROIC (6.20%) for ALNXT is below the current ROIC(6.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROIC 6.3%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • ALNXT's Profit Margin of 2.50% is in line compared to the rest of the industry. ALNXT outperforms 43.66% of its industry peers.
  • ALNXT's Profit Margin has declined in the last couple of years.
  • ALNXT's Operating Margin of 5.15% is in line compared to the rest of the industry. ALNXT outperforms 47.89% of its industry peers.
  • In the last couple of years the Operating Margin of ALNXT has declined.
  • ALNXT has a Gross Margin of 54.19%. This is comparable to the rest of the industry: ALNXT outperforms 40.85% of its industry peers.
  • ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALNXT.PA Health Analysis

2.1 Basic Checks

  • ALNXT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALNXT has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALNXT has more shares outstanding
  • Compared to 1 year ago, ALNXT has an improved debt to assets ratio.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALNXT has an Altman-Z score of 2.10. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.10, ALNXT perfoms like the industry average, outperforming 43.66% of the companies in the same industry.
  • The Debt to FCF ratio of ALNXT is 3.10, which is a good value as it means it would take ALNXT, 3.10 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.10, ALNXT is in line with its industry, outperforming 56.34% of the companies in the same industry.
  • ALNXT has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • ALNXT has a better Debt to Equity ratio (0.12) than 77.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Altman-Z 2.1
ROIC/WACC0.97
WACC6.49%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALNXT has a Current Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.25, ALNXT is in line with its industry, outperforming 52.11% of the companies in the same industry.
  • A Quick Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
  • ALNXT's Quick ratio of 1.25 is in line compared to the rest of the industry. ALNXT outperforms 59.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALNXT.PA Growth Analysis

3.1 Past

  • ALNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.13%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 3.66% on average over the past years.
  • Looking at the last year, ALNXT shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.
  • ALNXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.48% yearly.
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%

3.2 Future

  • Based on estimates for the next years, ALNXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.47% on average per year.
  • ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

7

4. ALNXT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.25, which indicates a very decent valuation of ALNXT.
  • Based on the Price/Earnings ratio, ALNXT is valued cheaper than 90.14% of the companies in the same industry.
  • ALNXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.88.
  • A Price/Forward Earnings ratio of 3.99 indicates a rather cheap valuation of ALNXT.
  • Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 92.96% of the companies in the same industry.
  • ALNXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.25
Fwd PE 3.99
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • ALNXT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALNXT is cheaper than 73.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.9
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.45
PEG (5Y)2.53
EPS Next 2Y9.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALNXT.PA Dividend Analysis

5.1 Amount

  • No dividends for ALNXT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALNXT.PA Fundamentals: All Metrics, Ratios and Statistics

NEXTEDIA

EPA:ALNXT (3/27/2026, 7:00:00 PM)

0.37

-0.01 (-2.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap14.43M
Revenue(TTM)62.04M
Net Income(TTM)1.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.25
Fwd PE 3.99
P/S 0.23
P/FCF 7.9
P/OCF 7.55
P/B 0.46
P/tB 12.45
EV/EBITDA N/A
EPS(TTM)0.04
EY10.81%
EPS(NY)0.09
Fwd EY25.05%
FCF(TTM)0.05
FCFY12.65%
OCF(TTM)0.05
OCFY13.24%
SpS1.59
BVpS0.81
TBVpS0.03
PEG (NY)0.45
PEG (5Y)2.53
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROCE 8.85%
ROIC 6.3%
ROICexc 7.81%
ROICexgc N/A
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
FCFM 2.94%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.82%
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.1
F-Score7
WACC6.49%
ROIC/WACC0.97
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.15%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y-33.49%
OCF growth 3Y-10.82%
OCF growth 5YN/A

NEXTEDIA / ALNXT.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.


What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.


What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 4 / 10.


How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.